0 Avaliações

ID

13640

Descrição

Phase II Study of the Role of Anti-CEA Antibody Immunoscintigraphy & Positron Emission Tomography in the Localization of Recurrent Colorectal Carcinoma in Patients With Rising Serum CEA Levels in the Absence of Imageable Disease by Conventional Modalities; ODM derived from: https://clinicaltrials.gov/show/NCT00001568

Link

https://clinicaltrials.gov/show/NCT00001568

Palavras-chave

  1. 22/02/2016 22/02/2016 -
Transferido a

22 de fevereiro de 2016

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :


    Sem comentários

    Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

    Eligibility Colorectal Neoplasm NCT00001568

    Eligibility Colorectal Neoplasm NCT00001568

    Criteria
    Descrição

    Criteria

    rising serum cea levels greater than 6 on two successive tests.
    Descrição

    cea levels

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0201933
    resectable residual or recurrent disease. patients in the occult arm (arm 1) must have no visible residual disease in the abdomen at the time of the last surgical exploration. in addition, there must be no imageable definitive site of recurrent disease using conventional imaging modalities including; ct scan of chest/ abdomen/ pelvis with contrast, mri scan, and chest x-ray. patients in arm 2 may have a single site of recurrent or metastatic disease which is resectable but in whom additional sites of disease are not known and no imageable disease other than a solitary site of potentially resectable disease is identified.
    Descrição

    Surgery, residual or recurrent disease, criteria for study groups

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0038894
    UMLS CUI [2]
    C0543478
    UMLS CUI [3]
    C0277556
    UMLS CUI [4]
    C0027627
    patients must have an ecog performance status of 0-1.
    Descrição

    ecog performance status

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C1520224
    patients must be willing to return to nih for follow-up.
    Descrição

    return to nih for follow-up

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C1321605
    patients must be able to provide informed consent as demonstrated by the signed consent.
    Descrição

    informed consent

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    patients must be 2 or more months from abdominal or thoracic surgery.
    Descrição

    surgery

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0038894
    no patients with medical contraindication to abdominal exploration.
    Descrição

    abdominal exploration

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0085704
    no patients with recurrent disease detected by conventional imaging studies as outlined above. metastatic disease localized outside of the abdominal cavity by conventional imaging studies as outlined above. patients must weigh less than 136 kgs. which is the weight limit for the scanner tables.
    Descrição

    recurrent disease, metastatic disease outside of the abdominal cavity, body weight

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0277556
    UMLS CUI [2]
    C0027627
    UMLS CUI [3]
    C0005910
    no patients with previous injection of murine monoclonal antibodies: human anti-mouse assay (hama) will be performed in patients with prior history of receiving murine monoclonal antibodies.
    Descrição

    prior murine monoclonal antibodies, hama test will be performed

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C2916903
    UMLS CUI [2]
    C1868744
    no patients that are pregnant or breast feeding.
    Descrição

    pregnant or breast feeding

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C0032961
    UMLS CUI [1,2]
    C0006147
    patients who are hiv + will be excluded.
    Descrição

    hiv

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0019682

    Similar models

    Eligibility Colorectal Neoplasm NCT00001568

    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de dados
    Alias
    Item Group
    cea levels
    Item
    rising serum cea levels greater than 6 on two successive tests.
    boolean
    C0201933 (UMLS CUI [1])
    Surgery, residual or recurrent disease, criteria for study groups
    Item
    resectable residual or recurrent disease. patients in the occult arm (arm 1) must have no visible residual disease in the abdomen at the time of the last surgical exploration. in addition, there must be no imageable definitive site of recurrent disease using conventional imaging modalities including; ct scan of chest/ abdomen/ pelvis with contrast, mri scan, and chest x-ray. patients in arm 2 may have a single site of recurrent or metastatic disease which is resectable but in whom additional sites of disease are not known and no imageable disease other than a solitary site of potentially resectable disease is identified.
    boolean
    C0038894 (UMLS CUI [1])
    C0543478 (UMLS CUI [2])
    C0277556 (UMLS CUI [3])
    C0027627 (UMLS CUI [4])
    ecog performance status
    Item
    patients must have an ecog performance status of 0-1.
    boolean
    C1520224 (UMLS CUI [1])
    return to nih for follow-up
    Item
    patients must be willing to return to nih for follow-up.
    boolean
    C1321605 (UMLS CUI [1])
    informed consent
    Item
    patients must be able to provide informed consent as demonstrated by the signed consent.
    boolean
    C0021430 (UMLS CUI [1])
    surgery
    Item
    patients must be 2 or more months from abdominal or thoracic surgery.
    boolean
    C0038894 (UMLS CUI [1])
    abdominal exploration
    Item
    no patients with medical contraindication to abdominal exploration.
    boolean
    C0085704 (UMLS CUI [1])
    recurrent disease, metastatic disease outside of the abdominal cavity, body weight
    Item
    no patients with recurrent disease detected by conventional imaging studies as outlined above. metastatic disease localized outside of the abdominal cavity by conventional imaging studies as outlined above. patients must weigh less than 136 kgs. which is the weight limit for the scanner tables.
    boolean
    C0277556 (UMLS CUI [1])
    C0027627 (UMLS CUI [2])
    C0005910 (UMLS CUI [3])
    prior murine monoclonal antibodies, hama test will be performed
    Item
    no patients with previous injection of murine monoclonal antibodies: human anti-mouse assay (hama) will be performed in patients with prior history of receiving murine monoclonal antibodies.
    boolean
    C2916903 (UMLS CUI [1])
    C1868744 (UMLS CUI [2])
    pregnant or breast feeding
    Item
    no patients that are pregnant or breast feeding.
    boolean
    C0032961 (UMLS CUI [1,1])
    C0006147 (UMLS CUI [1,2])
    hiv
    Item
    patients who are hiv + will be excluded.
    boolean
    C0019682 (UMLS CUI [1])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial